No tolerance development or suppression of natural healing processes has been observed with BPC-157 use
Mller TD, Clemmensen C, Finan B, DiMarchi RD, Tschp MH (2018) Anti-obesity therapy: from rainbow pills to polyagonists
Kaushal D, Contos JJ, Treuner K, Yang AH, Kingsbury MA, Rehen SK, et al
IGF-1 elevation : Chronic IGF-1 increase raises theoretical cancer risks and causes acromegalic changes
BPC-157 focuses more directly on repairing damaged tissues
Myo-inositol + D-chiro-inositol (2,050mg total in a 40:1 ratio): Research suggests that individuals with PCOS may experience disruptions in the balance between myo-inositol (MI) and D-chiro-inositol (DCI) two biologically active forms of inositol particularly in the ovaries